Global TB Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global TB Vaccines market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-GuŠ¹rin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the TB Vaccines industry chain, the market status of Hospitals (Immunotherapeutic Vaccines, Booster Vaccines), Private Clinics (Immunotherapeutic Vaccines, Booster Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of TB Vaccines.
Regionally, the report analyzes the TB Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global TB Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the TB Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the TB Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Immunotherapeutic Vaccines, Booster Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the TB Vaccines market.
Regional Analysis: The report involves examining the TB Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the TB Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to TB Vaccines:
Company Analysis: Report covers individual TB Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards TB Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Private Clinics).
Technology Analysis: Report covers specific technologies relevant to TB Vaccines. It assesses the current state, advancements, and potential future developments in TB Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the TB Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
TB Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe TB Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of TB Vaccines, with price, sales, revenue and global market share of TB Vaccines from 2019 to 2024.
Chapter 3, the TB Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the TB Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and TB Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of TB Vaccines.
Chapter 14 and 15, to describe TB Vaccines sales channel, distributors, customers, research findings and conclusion.
Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-GuŠ¹rin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the TB Vaccines industry chain, the market status of Hospitals (Immunotherapeutic Vaccines, Booster Vaccines), Private Clinics (Immunotherapeutic Vaccines, Booster Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of TB Vaccines.
Regionally, the report analyzes the TB Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global TB Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the TB Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the TB Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Immunotherapeutic Vaccines, Booster Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the TB Vaccines market.
Regional Analysis: The report involves examining the TB Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the TB Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to TB Vaccines:
Company Analysis: Report covers individual TB Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards TB Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Private Clinics).
Technology Analysis: Report covers specific technologies relevant to TB Vaccines. It assesses the current state, advancements, and potential future developments in TB Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the TB Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
TB Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Immunotherapeutic Vaccines
- Booster Vaccines
- Others
- Hospitals
- Private Clinics
- Research Institutes
- Merck & Co.,Inc
- Sanofi Pasteur
- Japan BCG Laboratory
- China National Biotec Group
- Serum Institute
- India Pvt. Ltd
- InterVax Ltd
- GreenSignal
- Bio Pharma Limited
- Statens Serum Institut
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe TB Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of TB Vaccines, with price, sales, revenue and global market share of TB Vaccines from 2019 to 2024.
Chapter 3, the TB Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the TB Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and TB Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of TB Vaccines.
Chapter 14 and 15, to describe TB Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of TB Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global TB Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Immunotherapeutic Vaccines
1.3.3 Booster Vaccines
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global TB Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Private Clinics
1.4.4 Research Institutes
1.5 Global TB Vaccines Market Size & Forecast
1.5.1 Global TB Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global TB Vaccines Sales Quantity (2019-2030)
1.5.3 Global TB Vaccines Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck & Co.,Inc
2.1.1 Merck & Co.,Inc Details
2.1.2 Merck & Co.,Inc Major Business
2.1.3 Merck & Co.,Inc TB Vaccines Product and Services
2.1.4 Merck & Co.,Inc TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck & Co.,Inc Recent Developments/Updates
2.2 Sanofi Pasteur
2.2.1 Sanofi Pasteur Details
2.2.2 Sanofi Pasteur Major Business
2.2.3 Sanofi Pasteur TB Vaccines Product and Services
2.2.4 Sanofi Pasteur TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Pasteur Recent Developments/Updates
2.3 Japan BCG Laboratory
2.3.1 Japan BCG Laboratory Details
2.3.2 Japan BCG Laboratory Major Business
2.3.3 Japan BCG Laboratory TB Vaccines Product and Services
2.3.4 Japan BCG Laboratory TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Japan BCG Laboratory Recent Developments/Updates
2.4 China National Biotec Group
2.4.1 China National Biotec Group Details
2.4.2 China National Biotec Group Major Business
2.4.3 China National Biotec Group TB Vaccines Product and Services
2.4.4 China National Biotec Group TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 China National Biotec Group Recent Developments/Updates
2.5 Serum Institute
2.5.1 Serum Institute Details
2.5.2 Serum Institute Major Business
2.5.3 Serum Institute TB Vaccines Product and Services
2.5.4 Serum Institute TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Serum Institute Recent Developments/Updates
2.6 India Pvt. Ltd
2.6.1 India Pvt. Ltd Details
2.6.2 India Pvt. Ltd Major Business
2.6.3 India Pvt. Ltd TB Vaccines Product and Services
2.6.4 India Pvt. Ltd TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 India Pvt. Ltd Recent Developments/Updates
2.7 InterVax Ltd
2.7.1 InterVax Ltd Details
2.7.2 InterVax Ltd Major Business
2.7.3 InterVax Ltd TB Vaccines Product and Services
2.7.4 InterVax Ltd TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 InterVax Ltd Recent Developments/Updates
2.8 GreenSignal
2.8.1 GreenSignal Details
2.8.2 GreenSignal Major Business
2.8.3 GreenSignal TB Vaccines Product and Services
2.8.4 GreenSignal TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 GreenSignal Recent Developments/Updates
2.9 Bio Pharma Limited
2.9.1 Bio Pharma Limited Details
2.9.2 Bio Pharma Limited Major Business
2.9.3 Bio Pharma Limited TB Vaccines Product and Services
2.9.4 Bio Pharma Limited TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Bio Pharma Limited Recent Developments/Updates
2.10 Statens Serum Institut
2.10.1 Statens Serum Institut Details
2.10.2 Statens Serum Institut Major Business
2.10.3 Statens Serum Institut TB Vaccines Product and Services
2.10.4 Statens Serum Institut TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Statens Serum Institut Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TB VACCINES BY MANUFACTURER
3.1 Global TB Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global TB Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global TB Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of TB Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 TB Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 TB Vaccines Manufacturer Market Share in 2023
3.5 TB Vaccines Market: Overall Company Footprint Analysis
3.5.1 TB Vaccines Market: Region Footprint
3.5.2 TB Vaccines Market: Company Product Type Footprint
3.5.3 TB Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global TB Vaccines Market Size by Region
4.1.1 Global TB Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global TB Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global TB Vaccines Average Price by Region (2019-2030)
4.2 North America TB Vaccines Consumption Value (2019-2030)
4.3 Europe TB Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific TB Vaccines Consumption Value (2019-2030)
4.5 South America TB Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa TB Vaccines Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global TB Vaccines Sales Quantity by Type (2019-2030)
5.2 Global TB Vaccines Consumption Value by Type (2019-2030)
5.3 Global TB Vaccines Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global TB Vaccines Sales Quantity by Application (2019-2030)
6.2 Global TB Vaccines Consumption Value by Application (2019-2030)
6.3 Global TB Vaccines Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America TB Vaccines Sales Quantity by Type (2019-2030)
7.2 North America TB Vaccines Sales Quantity by Application (2019-2030)
7.3 North America TB Vaccines Market Size by Country
7.3.1 North America TB Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America TB Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe TB Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe TB Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe TB Vaccines Market Size by Country
8.3.1 Europe TB Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe TB Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific TB Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific TB Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific TB Vaccines Market Size by Region
9.3.1 Asia-Pacific TB Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific TB Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America TB Vaccines Sales Quantity by Type (2019-2030)
10.2 South America TB Vaccines Sales Quantity by Application (2019-2030)
10.3 South America TB Vaccines Market Size by Country
10.3.1 South America TB Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America TB Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa TB Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa TB Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa TB Vaccines Market Size by Country
11.3.1 Middle East & Africa TB Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa TB Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 TB Vaccines Market Drivers
12.2 TB Vaccines Market Restraints
12.3 TB Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of TB Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of TB Vaccines
13.3 TB Vaccines Production Process
13.4 TB Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 TB Vaccines Typical Distributors
14.3 TB Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of TB Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global TB Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Immunotherapeutic Vaccines
1.3.3 Booster Vaccines
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global TB Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Private Clinics
1.4.4 Research Institutes
1.5 Global TB Vaccines Market Size & Forecast
1.5.1 Global TB Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global TB Vaccines Sales Quantity (2019-2030)
1.5.3 Global TB Vaccines Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck & Co.,Inc
2.1.1 Merck & Co.,Inc Details
2.1.2 Merck & Co.,Inc Major Business
2.1.3 Merck & Co.,Inc TB Vaccines Product and Services
2.1.4 Merck & Co.,Inc TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck & Co.,Inc Recent Developments/Updates
2.2 Sanofi Pasteur
2.2.1 Sanofi Pasteur Details
2.2.2 Sanofi Pasteur Major Business
2.2.3 Sanofi Pasteur TB Vaccines Product and Services
2.2.4 Sanofi Pasteur TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Pasteur Recent Developments/Updates
2.3 Japan BCG Laboratory
2.3.1 Japan BCG Laboratory Details
2.3.2 Japan BCG Laboratory Major Business
2.3.3 Japan BCG Laboratory TB Vaccines Product and Services
2.3.4 Japan BCG Laboratory TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Japan BCG Laboratory Recent Developments/Updates
2.4 China National Biotec Group
2.4.1 China National Biotec Group Details
2.4.2 China National Biotec Group Major Business
2.4.3 China National Biotec Group TB Vaccines Product and Services
2.4.4 China National Biotec Group TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 China National Biotec Group Recent Developments/Updates
2.5 Serum Institute
2.5.1 Serum Institute Details
2.5.2 Serum Institute Major Business
2.5.3 Serum Institute TB Vaccines Product and Services
2.5.4 Serum Institute TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Serum Institute Recent Developments/Updates
2.6 India Pvt. Ltd
2.6.1 India Pvt. Ltd Details
2.6.2 India Pvt. Ltd Major Business
2.6.3 India Pvt. Ltd TB Vaccines Product and Services
2.6.4 India Pvt. Ltd TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 India Pvt. Ltd Recent Developments/Updates
2.7 InterVax Ltd
2.7.1 InterVax Ltd Details
2.7.2 InterVax Ltd Major Business
2.7.3 InterVax Ltd TB Vaccines Product and Services
2.7.4 InterVax Ltd TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 InterVax Ltd Recent Developments/Updates
2.8 GreenSignal
2.8.1 GreenSignal Details
2.8.2 GreenSignal Major Business
2.8.3 GreenSignal TB Vaccines Product and Services
2.8.4 GreenSignal TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 GreenSignal Recent Developments/Updates
2.9 Bio Pharma Limited
2.9.1 Bio Pharma Limited Details
2.9.2 Bio Pharma Limited Major Business
2.9.3 Bio Pharma Limited TB Vaccines Product and Services
2.9.4 Bio Pharma Limited TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Bio Pharma Limited Recent Developments/Updates
2.10 Statens Serum Institut
2.10.1 Statens Serum Institut Details
2.10.2 Statens Serum Institut Major Business
2.10.3 Statens Serum Institut TB Vaccines Product and Services
2.10.4 Statens Serum Institut TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Statens Serum Institut Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TB VACCINES BY MANUFACTURER
3.1 Global TB Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global TB Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global TB Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of TB Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 TB Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 TB Vaccines Manufacturer Market Share in 2023
3.5 TB Vaccines Market: Overall Company Footprint Analysis
3.5.1 TB Vaccines Market: Region Footprint
3.5.2 TB Vaccines Market: Company Product Type Footprint
3.5.3 TB Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global TB Vaccines Market Size by Region
4.1.1 Global TB Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global TB Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global TB Vaccines Average Price by Region (2019-2030)
4.2 North America TB Vaccines Consumption Value (2019-2030)
4.3 Europe TB Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific TB Vaccines Consumption Value (2019-2030)
4.5 South America TB Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa TB Vaccines Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global TB Vaccines Sales Quantity by Type (2019-2030)
5.2 Global TB Vaccines Consumption Value by Type (2019-2030)
5.3 Global TB Vaccines Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global TB Vaccines Sales Quantity by Application (2019-2030)
6.2 Global TB Vaccines Consumption Value by Application (2019-2030)
6.3 Global TB Vaccines Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America TB Vaccines Sales Quantity by Type (2019-2030)
7.2 North America TB Vaccines Sales Quantity by Application (2019-2030)
7.3 North America TB Vaccines Market Size by Country
7.3.1 North America TB Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America TB Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe TB Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe TB Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe TB Vaccines Market Size by Country
8.3.1 Europe TB Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe TB Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific TB Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific TB Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific TB Vaccines Market Size by Region
9.3.1 Asia-Pacific TB Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific TB Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America TB Vaccines Sales Quantity by Type (2019-2030)
10.2 South America TB Vaccines Sales Quantity by Application (2019-2030)
10.3 South America TB Vaccines Market Size by Country
10.3.1 South America TB Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America TB Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa TB Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa TB Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa TB Vaccines Market Size by Country
11.3.1 Middle East & Africa TB Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa TB Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 TB Vaccines Market Drivers
12.2 TB Vaccines Market Restraints
12.3 TB Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of TB Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of TB Vaccines
13.3 TB Vaccines Production Process
13.4 TB Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 TB Vaccines Typical Distributors
14.3 TB Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global TB Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global TB Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck & Co.,Inc Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co.,Inc Major Business
Table 5. Merck & Co.,Inc TB Vaccines Product and Services
Table 6. Merck & Co.,Inc TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck & Co.,Inc Recent Developments/Updates
Table 8. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Pasteur Major Business
Table 10. Sanofi Pasteur TB Vaccines Product and Services
Table 11. Sanofi Pasteur TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Pasteur Recent Developments/Updates
Table 13. Japan BCG Laboratory Basic Information, Manufacturing Base and Competitors
Table 14. Japan BCG Laboratory Major Business
Table 15. Japan BCG Laboratory TB Vaccines Product and Services
Table 16. Japan BCG Laboratory TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Japan BCG Laboratory Recent Developments/Updates
Table 18. China National Biotec Group Basic Information, Manufacturing Base and Competitors
Table 19. China National Biotec Group Major Business
Table 20. China National Biotec Group TB Vaccines Product and Services
Table 21. China National Biotec Group TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. China National Biotec Group Recent Developments/Updates
Table 23. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute Major Business
Table 25. Serum Institute TB Vaccines Product and Services
Table 26. Serum Institute TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Serum Institute Recent Developments/Updates
Table 28. India Pvt. Ltd Basic Information, Manufacturing Base and Competitors
Table 29. India Pvt. Ltd Major Business
Table 30. India Pvt. Ltd TB Vaccines Product and Services
Table 31. India Pvt. Ltd TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. India Pvt. Ltd Recent Developments/Updates
Table 33. InterVax Ltd Basic Information, Manufacturing Base and Competitors
Table 34. InterVax Ltd Major Business
Table 35. InterVax Ltd TB Vaccines Product and Services
Table 36. InterVax Ltd TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. InterVax Ltd Recent Developments/Updates
Table 38. GreenSignal Basic Information, Manufacturing Base and Competitors
Table 39. GreenSignal Major Business
Table 40. GreenSignal TB Vaccines Product and Services
Table 41. GreenSignal TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. GreenSignal Recent Developments/Updates
Table 43. Bio Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 44. Bio Pharma Limited Major Business
Table 45. Bio Pharma Limited TB Vaccines Product and Services
Table 46. Bio Pharma Limited TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Bio Pharma Limited Recent Developments/Updates
Table 48. Statens Serum Institut Basic Information, Manufacturing Base and Competitors
Table 49. Statens Serum Institut Major Business
Table 50. Statens Serum Institut TB Vaccines Product and Services
Table 51. Statens Serum Institut TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Statens Serum Institut Recent Developments/Updates
Table 53. Global TB Vaccines Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global TB Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global TB Vaccines Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 56. Market Position of Manufacturers in TB Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and TB Vaccines Production Site of Key Manufacturer
Table 58. TB Vaccines Market: Company Product Type Footprint
Table 59. TB Vaccines Market: Company Product Application Footprint
Table 60. TB Vaccines New Market Entrants and Barriers to Market Entry
Table 61. TB Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global TB Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 63. Global TB Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 64. Global TB Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global TB Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global TB Vaccines Average Price by Region (2019-2024) & (USD/Unit)
Table 67. Global TB Vaccines Average Price by Region (2025-2030) & (USD/Unit)
Table 68. Global TB Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Global TB Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Global TB Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global TB Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global TB Vaccines Average Price by Type (2019-2024) & (USD/Unit)
Table 73. Global TB Vaccines Average Price by Type (2025-2030) & (USD/Unit)
Table 74. Global TB Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Global TB Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Global TB Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global TB Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global TB Vaccines Average Price by Application (2019-2024) & (USD/Unit)
Table 79. Global TB Vaccines Average Price by Application (2025-2030) & (USD/Unit)
Table 80. North America TB Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 81. North America TB Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 82. North America TB Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 83. North America TB Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 84. North America TB Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 85. North America TB Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 86. North America TB Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America TB Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe TB Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Europe TB Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Europe TB Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 91. Europe TB Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 92. Europe TB Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Europe TB Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Europe TB Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe TB Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific TB Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 97. Asia-Pacific TB Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 98. Asia-Pacific TB Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 99. Asia-Pacific TB Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 100. Asia-Pacific TB Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 101. Asia-Pacific TB Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 102. Asia-Pacific TB Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific TB Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America TB Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 105. South America TB Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 106. South America TB Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 107. South America TB Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 108. South America TB Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 109. South America TB Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 110. South America TB Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America TB Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa TB Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 113. Middle East & Africa TB Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 114. Middle East & Africa TB Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Middle East & Africa TB Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Middle East & Africa TB Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 117. Middle East & Africa TB Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 118. Middle East & Africa TB Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa TB Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 120. TB Vaccines Raw Material
Table 121. Key Manufacturers of TB Vaccines Raw Materials
Table 122. TB Vaccines Typical Distributors
Table 123. TB Vaccines Typical Customers
Table 1. Global TB Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global TB Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck & Co.,Inc Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co.,Inc Major Business
Table 5. Merck & Co.,Inc TB Vaccines Product and Services
Table 6. Merck & Co.,Inc TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck & Co.,Inc Recent Developments/Updates
Table 8. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Pasteur Major Business
Table 10. Sanofi Pasteur TB Vaccines Product and Services
Table 11. Sanofi Pasteur TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Pasteur Recent Developments/Updates
Table 13. Japan BCG Laboratory Basic Information, Manufacturing Base and Competitors
Table 14. Japan BCG Laboratory Major Business
Table 15. Japan BCG Laboratory TB Vaccines Product and Services
Table 16. Japan BCG Laboratory TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Japan BCG Laboratory Recent Developments/Updates
Table 18. China National Biotec Group Basic Information, Manufacturing Base and Competitors
Table 19. China National Biotec Group Major Business
Table 20. China National Biotec Group TB Vaccines Product and Services
Table 21. China National Biotec Group TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. China National Biotec Group Recent Developments/Updates
Table 23. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute Major Business
Table 25. Serum Institute TB Vaccines Product and Services
Table 26. Serum Institute TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Serum Institute Recent Developments/Updates
Table 28. India Pvt. Ltd Basic Information, Manufacturing Base and Competitors
Table 29. India Pvt. Ltd Major Business
Table 30. India Pvt. Ltd TB Vaccines Product and Services
Table 31. India Pvt. Ltd TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. India Pvt. Ltd Recent Developments/Updates
Table 33. InterVax Ltd Basic Information, Manufacturing Base and Competitors
Table 34. InterVax Ltd Major Business
Table 35. InterVax Ltd TB Vaccines Product and Services
Table 36. InterVax Ltd TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. InterVax Ltd Recent Developments/Updates
Table 38. GreenSignal Basic Information, Manufacturing Base and Competitors
Table 39. GreenSignal Major Business
Table 40. GreenSignal TB Vaccines Product and Services
Table 41. GreenSignal TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. GreenSignal Recent Developments/Updates
Table 43. Bio Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 44. Bio Pharma Limited Major Business
Table 45. Bio Pharma Limited TB Vaccines Product and Services
Table 46. Bio Pharma Limited TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Bio Pharma Limited Recent Developments/Updates
Table 48. Statens Serum Institut Basic Information, Manufacturing Base and Competitors
Table 49. Statens Serum Institut Major Business
Table 50. Statens Serum Institut TB Vaccines Product and Services
Table 51. Statens Serum Institut TB Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Statens Serum Institut Recent Developments/Updates
Table 53. Global TB Vaccines Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global TB Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global TB Vaccines Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 56. Market Position of Manufacturers in TB Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and TB Vaccines Production Site of Key Manufacturer
Table 58. TB Vaccines Market: Company Product Type Footprint
Table 59. TB Vaccines Market: Company Product Application Footprint
Table 60. TB Vaccines New Market Entrants and Barriers to Market Entry
Table 61. TB Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global TB Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 63. Global TB Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 64. Global TB Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global TB Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global TB Vaccines Average Price by Region (2019-2024) & (USD/Unit)
Table 67. Global TB Vaccines Average Price by Region (2025-2030) & (USD/Unit)
Table 68. Global TB Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Global TB Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Global TB Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global TB Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global TB Vaccines Average Price by Type (2019-2024) & (USD/Unit)
Table 73. Global TB Vaccines Average Price by Type (2025-2030) & (USD/Unit)
Table 74. Global TB Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Global TB Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Global TB Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global TB Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global TB Vaccines Average Price by Application (2019-2024) & (USD/Unit)
Table 79. Global TB Vaccines Average Price by Application (2025-2030) & (USD/Unit)
Table 80. North America TB Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 81. North America TB Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 82. North America TB Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 83. North America TB Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 84. North America TB Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 85. North America TB Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 86. North America TB Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America TB Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe TB Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Europe TB Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Europe TB Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 91. Europe TB Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 92. Europe TB Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Europe TB Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Europe TB Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe TB Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific TB Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 97. Asia-Pacific TB Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 98. Asia-Pacific TB Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 99. Asia-Pacific TB Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 100. Asia-Pacific TB Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 101. Asia-Pacific TB Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 102. Asia-Pacific TB Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific TB Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America TB Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 105. South America TB Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 106. South America TB Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 107. South America TB Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 108. South America TB Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 109. South America TB Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 110. South America TB Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America TB Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa TB Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 113. Middle East & Africa TB Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 114. Middle East & Africa TB Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Middle East & Africa TB Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Middle East & Africa TB Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 117. Middle East & Africa TB Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 118. Middle East & Africa TB Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa TB Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 120. TB Vaccines Raw Material
Table 121. Key Manufacturers of TB Vaccines Raw Materials
Table 122. TB Vaccines Typical Distributors
Table 123. TB Vaccines Typical Customers
LIST OF FIGURES
Figure 1. TB Vaccines Picture
Figure 2. Global TB Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global TB Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Immunotherapeutic Vaccines Examples
Figure 5. Booster Vaccines Examples
Figure 6. Others Examples
Figure 7. Global TB Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global TB Vaccines Consumption Value Market Share by Application in 2023
Figure 9. Hospitals Examples
Figure 10. Private Clinics Examples
Figure 11. Research Institutes Examples
Figure 12. Global TB Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global TB Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global TB Vaccines Sales Quantity (2019-2030) & (K Units)
Figure 15. Global TB Vaccines Average Price (2019-2030) & (USD/Unit)
Figure 16. Global TB Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global TB Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of TB Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 TB Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 TB Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global TB Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global TB Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 23. North America TB Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe TB Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific TB Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. South America TB Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa TB Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 28. Global TB Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global TB Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 30. Global TB Vaccines Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global TB Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global TB Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 33. Global TB Vaccines Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America TB Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America TB Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America TB Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America TB Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 38. United States TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe TB Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe TB Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe TB Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe TB Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific TB Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific TB Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific TB Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific TB Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 54. China TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America TB Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America TB Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America TB Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America TB Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa TB Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa TB Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa TB Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa TB Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. TB Vaccines Market Drivers
Figure 75. TB Vaccines Market Restraints
Figure 76. TB Vaccines Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of TB Vaccines in 2023
Figure 79. Manufacturing Process Analysis of TB Vaccines
Figure 80. TB Vaccines Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. TB Vaccines Picture
Figure 2. Global TB Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global TB Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Immunotherapeutic Vaccines Examples
Figure 5. Booster Vaccines Examples
Figure 6. Others Examples
Figure 7. Global TB Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global TB Vaccines Consumption Value Market Share by Application in 2023
Figure 9. Hospitals Examples
Figure 10. Private Clinics Examples
Figure 11. Research Institutes Examples
Figure 12. Global TB Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global TB Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global TB Vaccines Sales Quantity (2019-2030) & (K Units)
Figure 15. Global TB Vaccines Average Price (2019-2030) & (USD/Unit)
Figure 16. Global TB Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global TB Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of TB Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 TB Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 TB Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global TB Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global TB Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 23. North America TB Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe TB Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific TB Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. South America TB Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa TB Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 28. Global TB Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global TB Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 30. Global TB Vaccines Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global TB Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global TB Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 33. Global TB Vaccines Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America TB Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America TB Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America TB Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America TB Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 38. United States TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe TB Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe TB Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe TB Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe TB Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific TB Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific TB Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific TB Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific TB Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 54. China TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America TB Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America TB Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America TB Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America TB Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa TB Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa TB Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa TB Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa TB Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa TB Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. TB Vaccines Market Drivers
Figure 75. TB Vaccines Market Restraints
Figure 76. TB Vaccines Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of TB Vaccines in 2023
Figure 79. Manufacturing Process Analysis of TB Vaccines
Figure 80. TB Vaccines Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
